What is the current number of medicinal cannabis prescriptions in Australia so far? In just a few years, the number of medicinal cannabis prescriptions through the Special Access Scheme B (SAS-B) has grown substantially. It still represents a small percentage of the overall Australian population who state they rely on cannabis for medicinal purposes. Only…
Naloxone Access Pilot Programs (FAQs) This article will review FAQs in relation to Naloxone Access Programs being rolled out in various jurisdictions, including the ‘Take Home Naloxone’ pilot program in Australia – and why these programs need your support. Disclaimer: This article is for education purposes only. This content is NOT for use for training…
After Mind Medicine’s very successful International Summit on Psychedelic Therapies for Mental Illness, I’m sure the nascent industry is ablaze with ideas and inspiration. The down-scheduling decision on MDMA and psilocybin is due to be released in Dec 2021, and one of the last things we were asked to do as participants of the summit…
“Reducing stigma, saving lives” is the final blog in the 10 blog series on overdose awareness and overdose prevention topics. Did you miss the latest overdose research and overdose statistics report, released on the 31st of August 2021 (International Overdose Awareness Day)? The 2021 overdose research report was compiled and published by John Ryan and…
Glancing at headlines these days there appears to be a consistent stream of positive news breaking out all over the world about the potential therapeutic benefits of psychedelics, including a declaration from the FDA that psilocybin is a “breakthrough therapy.” Australia has also been involved in conducting some of the research and there are ongoing…
Please complete the form on the contact us page. We will get back to you within one business day.
Phone: +61 3 9887 6412
Email: [email protected]
